A real-world pattern on the long-term durability of the immune response to hepatitis B vaccination among people living with HIV in China: an 8.5-year retrospective study.

Heplisav-B (hepatitis B vaccine (recombinant), adjuvanted) - Dynavax, Sanofi

http://www.ncbi.nlm.nih.gov/pubmed/42666258

Honghong Yang; Jingmin Nie; Lvlang Zhang; Pengle Guo; Tongxin Li; Xiang Du

Aug 30, 2026